- UnitedHealth(NYSE:UNH): Q2 Non-GAAP EPS of $5.57beats by $0.37.
- Revenue of $80.3B (+12.6% Y/Y)beats by $620M.
- Revenues of $80.3 Billion Grew 13% Year-Over-Year, with Double-Digit Growth at both Optum and UnitedHealthcare
- The second quarter 2022 medical care ratio was 81.5% compared to 82.8% last year, due to COVID effects and business mix.
- The second quarter 2022 operating cost ratio of 14.6% compares to 14.5% in 2021, reflecting continued productivity gains, offset by business mix and the investments the company continues to make to support future growth opportunities.
Based upon the first half performance and growth expectations, the company increased its full year net earnings outlook to $20.45 to $20.95 per share and adjusted net earnings to $21.40 to $21.90 per share vs. $21.68 consensus, from prior outlook of $21.20-$21.70. Growth in the second quarter was balanced across the company’s businesses, driven especially by continued strong expansion in people served at UnitedHealthcare and in value-based arrangements at Optum Health.
